Lipocine Inc. sell Marianka
Start price
21.03.22
/
70%
€25.25
Target price
21.03.23
€0.000
Performance (%)
-19.90%
End price
02.04.22
€20.22
Summary
This prediction ended on 02.04.22 with a price of €20.22. The prediction for Lipocine Inc. closed with a convincing performance of -19.90%. Marianka has 70% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Lipocine Inc. | - | - | - |
| iShares Core DAX® | 2.594% | -1.861% | 13.242% |
| iShares Nasdaq 100 | 3.553% | -2.064% | 38.293% |
| iShares Nikkei 225® | 0.687% | -8.704% | 17.510% |
| iShares S&P 500 | 2.209% | -1.988% | 27.632% |
According to Marianka what are the pros and cons of Lipocine Inc. for the foreseeable future?
Pros
Some uniques
Top 10 in its market
Fair valuation
Cons
Below average Management
high free float
High risks for its business
Unknown brand
Bad culture
No Innovation
Dependend from few customers or products
Growths much slower than the competition
Sustainability is not important
Very high cyclical dependencies
Outdated or very high risk business model
Risky Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
very negative Cash Flow expected
Very low/no dividend yield expected
Junk rating
Very little Investments for future growth
Risky balance sheet
ROE lower than 5% per year
Increased challenges to pay loans and raise capital
Comments by Marianka for this prediction
In the thread Lipocine Inc diskutieren
Sell mit Kursziel 0,0